Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®

Inclusion Criteria:

• Signed consent obtained before any study-related activities (study-relatedactivities are any procedure related to recording of data according to theprotocol).

• The decision to initiate treatment with commercially available Ozempic® has beenmade by the patient/Legally Acceptable Representative (LAR) and the treatingphysician before and independently from the decision to include the patient in thisstudy.

• Patients with Diabetes Mellitus, Type 2 (T2DM) who the physician has decided tostart treatment with Ozempic®.

• Male or female, no age limitation.

Exclusion Criteria:

• Previous participation in this study. Participation is defined as having giveninformed consent in this study.

• Mental incapacity, unwillingness or language barriers precluding adequateunderstanding or cooperation.

• Patients who fall under contraindications to the label.

• Patients who are or have previously been treated with Ozempic®.

• Female who is pregnant, breast-feeding or intends to become pregnant.